Inventor

Steffen Goletz

Inventor
Glienicke/Nordbahn, DE

Overview

25→
Patents
2009–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C12NMicroorganisms or enzymes14%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for3%
Y02ATechnologies for adaptation to climate change3%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution3%
A23CDairy products, e.g. milk, butter or cheese1%
PatentTitleYear
10,280,230Use of human cells of myeloid leukemia origin for expression of antibodies201910,184,135Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters20199,845,361Recognition molecules for the treatment and detection of tumors20179,700,610'Microorganisms carrying a tumor antigen'20179,527,899'Recombinant human follicle-stimulating hormone'20169,494,587'Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates'20169,487,567'Method for the production of an immunostimulating mucin (MUC1)'20169,359,439'Fab-glycosylated antibodies'20169,345,794'Tumor-specific recognition molecules'20169,217,038'MUC1 antibodies'20159,051,370'Humanized EGFR antibodies'20159,051,356'Use of human cells of myeloid leukaemia origin for expression of antibodies'20159,029,143'MUTZ-3 dendritic cells'20158,846,344'Process for the purification of glycoproteins'20148,779,102'Recognition molecules for the treatment and detection of tumors'20148,741,365'Fermentation process'20148,642,276'Method for the production of an immunostimulating mucin (MUC1)'20148,617,846'Tumor-specific recognition molecules'20138,609,370'Highly active glycoproteins-process conditions and an efficient method for their production'20138,592,165'Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof'20138,455,253'Differentiation of MUTZ-3 cells to produce effective dendritic cells'20138,283,161'Tumour cell lines and uses thereof'20128,088,357'Tumor-specific recognition molecules'20128,017,388'Tumour cell lines and uses thereof'20117,595,192'Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2019Patents assigned to GLYCOTOPE GMBH (24)· patent assignee history
2009–2015Based in Glienicke, DE· patent location history
2012–2017Patents assigned to GOLETZ STEFFEN (18)· patent assignee history
2012–2016Patents assigned to DANIELCZYK ANTJE (7)· patent assignee history
2012–2015Patents assigned to KARSTEN UWE (5)· patent assignee history
2012–2015Patents assigned to STAHN RENATE (5)· patent assignee history
2012–2017Based in Glienicke/Nordbahn, DE· patent location history
2014–2019Based in Berlin, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GLYCOTOPE GMBH242009–2019
GOLETZ STEFFENself182012–2017
DANIELCZYK ANTJE72012–2016
KARSTEN UWE52012–2015
STAHN RENATE52012–2015
Locations
LocationPatentsSpan
Glienicke/Nordbahn, DE112012–2017
Berlin, DE82014–2019
Glienicke, DE62009–2015